New publications in health economics and genomics 22nd February 2022

One publication from the past week:

  • Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 15th February 2022

Two publications from the past week:

  • Health economic evidence for the use of molecular biomarker tests in hematological malignancies: a systematic review | link
  • Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 1st February 2022

Three publications from the past week:

  • Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol | link
  • Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design | link
  • Economic evaluation in psychiatric pharmacogenomics: a systematic review | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 25th January 2022

Two publications from the past week:

  • Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology | link
  • Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 18th January 2022

Two publications from the past week:

  • Developing new frameworks to value genomic information: accounting for complexity | link
  • Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 4th January 2022

A bumper crop of publications from the holiday period:

  • Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases | link
  • The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence | link
  • Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy | link
  • Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients | link
  • Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link
  • The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening | link
  • Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 7th December 2021

One publication from the past week:

  • Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 30th November 2021

One publication from the past week:

  • Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd November 2021

Two publications from the past week:

  • The diagnostic trajectory of infants and children with clinical features of genetic disease | link
  • Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th November 2021

Three publications from the past week:

  • Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis | link
  • 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report | link
  • Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.